Recruiting
Phase 2

Certolizumab

Sponsor:

David Ware Branch

Code:

NCT03152058

Conditions

High Risk Pregnancy

Pregnancy Complications

Antiphospholipid Syndrome in Pregnancy

Lupus Anticoagulant Disorder

Eligibility Criteria

Sex: Female

Age: 18 - 40

Healthy Volunteers: Not accepted

Interventions

Certolizumab Pegol

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by David Ware Branch on 2024-12-11.